# Test and Treat COVID 65plus+

> **NCT04351516** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **University Hospital Tuebingen**

## Conditions studied

- SARS-CoV 2
- COVID-19

## Interventions

- **DRUG:** Hydroxychloroquine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04351516
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-04-21
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-05-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No Patients enrolled
- **Last updated:** 2021-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04351516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04351516, "Test and Treat COVID 65plus+". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04351516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*